CDW enters the post-earnings stretch carrying two contradictory signals: revenue that surprised to the upside and a short book that has grown 22% in a month.
Q1 results, reported this morning, set the tone for the week. Sales came in at $5.68 billion, clearing the consensus estimate of $5.48 billion by roughly 4%. Adjusted EPS of $2.28 fell just a whisker short of the $2.29 forecast. That near-miss was enough to send the stock to a 52-week intraday low before buyers stepped in. It closed at $136.80, up 1.1% on the day and 2.9% on the week — a meaningful reversal from the session's depths. AI infrastructure demand and commercial hardware growth were cited as drivers of the revenue outperformance.
The most striking single data point from today, however, was not the earnings print itself but what happened to options flow. The put/call ratio collapsed to 0.585 — more than four standard deviations below its 20-day mean of 1.01. For a stock that has traded with a fairly consistent PCR in the 1.0–1.07 band throughout April, today's spike in call-buying is dramatic. Whether that reflects positioning for a bounce off the 52-week low or genuine conviction in the revenue story, the options market swung sharply bullish in a single session. The 52-week PCR low is 0.073, so there is room to go further, but the move from near the annual high (1.11) to 0.585 in days is a notable sentiment shift.
Short interest complicates that optimistic read. Bears have added aggressively over the past six weeks, with SI % of free float climbing from roughly 3.9% in mid-April to 5.09% now — a 22% increase in shares short over 30 days. The build accelerated sharply around April 23–24, when short positions jumped by more than 1.2 million shares in two sessions. That timing coincides with the point the stock was rolling off from the mid-$120s bounce. Borrow costs remain trivial at 0.38%, and availability is nowhere near tight, meaning new short positions are easy to put on. The short score of 40.8 is moderate — not at an extreme — but the directional trend in positioning is clearly bearish.
Analyst sentiment is cautious and largely stale from the February reporting cycle. Following the last earnings print, JP Morgan trimmed its target from $170 to $160 while keeping a Neutral rating; UBS held at Buy but cut from $190 to $162; Barclays and Morgan Stanley both maintained equal-weight calls with slightly reduced targets in the low $140s. The consensus mean target of $160.20 implies roughly 17% upside from current levels — a gap that widened materially when the stock broke to new lows this morning. On valuation, the P/E of 12.65 has expanded by just over one turn in the past month on the back of the stock's 12% rebound, and EV/EBITDA sits near 10.5. The forward earnings yield factor ranks in the 78th percentile versus peers — one of the stronger value signals on the scorecard. EPS momentum over both 30 and 90 days ranks in the low 30s, reflecting muted near-term estimate revisions ahead of today's slight miss.
Among correlated peers, SNX — one of CDW's closest technology distributor comparables — gained 3% on the day and 5.1% on the week, suggesting the sector backdrop is broadly supportive rather than CDW-specific weakness driving the short build. ARW rose just 0.5% on the week, more in line with CDW's own move.
What to watch next is how quickly the Q1 revenue beat translates into estimate revisions — and whether fresh analyst targets following today's print narrow the spread between a $136 stock and a $160 consensus target, or whether the modest EPS miss is enough to keep the Street sidelined heading into the next event on May 21.
See the live data behind this article on ORTEX.
Open CDW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
